Science
Mechanism of Action
This extract operates via several key mechanisms: it robustly scavenges free radicals and activates the skin's intrinsic antioxidant defense systems, primarily due to its high concentration of polyphenols and flavonoids. Its anti-inflammatory action is achieved by inhibiting the production of prostaglandin E2 (PGE2) through the suppression of cyclooxygenase-2 (COX-2), and by limiting inflammatory cytokines such as NO, TNF-α, IL-1β, IL-6, and NF-κB, driven by compounds like luteolin. Furthermore, its essential oils demonstrate antimicrobial efficacy against skin bacteria, including P. acnes, S. aureus, and S. epidermidis, which are associated with acne development.
Research
Clinical Evidence
Medium confidenceN/A
Key findings
- 01 In vitro, concentrations between 0.0005% (5 µg/mL) and 0.01% (100 µg/mL) effectively inhibited PGE2 production, demonstrating anti-inflammatory action.
- 02 Essential oils from the extract showed inhibitory activity against P. acnes with a minimum inhibitory concentration (MIC) of approximately 0.031% (0.31 µL/mL), suggesting anti-acne potential.
- 03 Antioxidant activity was observed in a concentration-dependent manner, with 0.08% (0.8 mg/mL) identified as an optimal concentration for maximizing loading efficiency in nanoparticles.
Transparency
Dusting Analysis
Insufficient data available to determine dusting practices or associated thresholds for this ingredient within cosmetic formulations.
The Formula
Formulation
Stability
Specific pH stability and additional stability characteristics are not detailed in the available research.
Safety
Safety Profile
Oral administration of Elsholtzia splendens extracts in mice up to 2000 mg/kg body weight/day for 15 days showed no significant mortality or adverse clinical signs. It did not induce mutagenicity in bacterial reverse mutation assays. However, an in vitro chromosome aberration assay in Chinese Hamster Lung (CHL) cells indicated a significant increase in chromosomal aberrations at the highest concentration (0.5% or 5000 µg/mL) after 22 hours without metabolic activation. This finding suggests a potential genotoxic effect at high concentrations in vitro, requiring further comprehensive study to assess its relevance for topical application. The Cosmetic Ingredient Review (CIR) has not published a final safety assessment for this ingredient.
Your Skin
Skin Compatibility
Our Assessment
Verdict
Elsholtzia Splendens offers promising antioxidant, anti-inflammatory, and antimicrobial benefits for skin, but comprehensive safety evaluations, particularly regarding potential genotoxic effects at high concentrations in vivo, are warranted for its inclusion in precision formulations.
Related
Similar Ingredients
Finding similar ingredients…
References
Sources